338 related articles for article (PubMed ID: 15585026)
1. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
[TBL] [Abstract][Full Text] [Related]
2. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
3. Visual scoring versus histogram subtraction of in vivo binding of immunoglobulins against platelets after transfusion.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Cytometry B Clin Cytom; 2004 Jan; 57(1):40-6. PubMed ID: 14696062
[TBL] [Abstract][Full Text] [Related]
4. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
Yam P; Petz LD; Scott EP; Santos S
Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
Wiita AP; Nambiar A
Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
[TBL] [Abstract][Full Text] [Related]
6. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
7. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
[TBL] [Abstract][Full Text] [Related]
8. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
9. A microplate ELISA for the detection of platelet alloantibodies: comparison with the platelet immunofluorescence test.
Sintnicolaas K; van der Steuijt KJ; van Putten WL; Bolhuis RL
Br J Haematol; 1987 Jul; 66(3):363-7. PubMed ID: 3304393
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
[TBL] [Abstract][Full Text] [Related]
11. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study.
Levin MD; de Veld JC; van der Holt B; van 't Veer MB
Ann Hematol; 2003 Jun; 82(6):357-62. PubMed ID: 12719885
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of flow cytometry as a platelet crossmatching procedure.
Gates K; MacPherson BR
Cytometry; 1994 Sep; 18(3):123-8. PubMed ID: 7813332
[TBL] [Abstract][Full Text] [Related]
13. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantitation of platelet-associated IgG in thrombocytopenia: a comparison of immunofluorescence and immunoenzyme techniques.
Smith GA; Herron R
Med Lab Sci; 1989 Jan; 46(1):45-9. PubMed ID: 2674579
[TBL] [Abstract][Full Text] [Related]
15. Detection of HLA antibodies by platelet crossmatching techniques.
McGrath K; Holdsworth R; Veale M; Bishop J; Wolf M
Transfusion; 1988; 28(3):214-6. PubMed ID: 3285524
[TBL] [Abstract][Full Text] [Related]
16. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
[TBL] [Abstract][Full Text] [Related]
17. The level of matrix metalloproteinase-2 in donor plasma strongly correlates with post-transfusion recovery of stored platelet concentrates.
Mutlu A; Allen DJ; Freedman J; Leytin V
Vox Sang; 2008 Feb; 94(2):143-5. PubMed ID: 18028261
[TBL] [Abstract][Full Text] [Related]
18. [Application of microcolumn gel immunoassay in screening the platelet antibody].
Xu DY; Dong GF; Zhang Z; Peng MX; Du Y; Chen CS; Tang XX; Fu JY; Gao JL; Bai J; Ma YL; Qian BY; Ma JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):888-91. PubMed ID: 17708827
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patients.
Tosetto A; Ruggeri M; Schiavotto C; Pellizzari G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):41-6. PubMed ID: 8039757
[TBL] [Abstract][Full Text] [Related]
20. The alloimmunized patient: effective transfusion support and newer experimental approaches.
Pamphilon DH
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):651-4. PubMed ID: 1450334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
